{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-332870","form_type":"8-K","ticker":"ATEC","cik":"0001350653","company_name":"Alphatec Holdings, Inc.","filed_at":"2026-08-04T20:19:19+00:00","discovered_at":"2026-08-04T20:20:00.400300+00:00","generated_at":"2026-08-04T20:20:18.244016+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"ATEC Q2 revenue $214M (+15% YoY); raises FY2026 adjusted EBITDA guidance to $140M","bullets":["Total revenue $214M (+15% YoY); surgical revenue $196M (+17% YoY) on 20% case volume growth.","GAAP net loss $26M; Non-GAAP net income $11M; adjusted EBITDA $36M (16.8% margin, +420 bps YoY).","Net new surgeon users +24%; ending cash $119M; positive free cash flow.","FY2026 revenue reaffirmed at ~$882M; adjusted EBITDA guidance raised to ~$140M (from ~$134M).","Expects at least $20M free cash flow for FY2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-332870","json":"https://secwatch.observer/filing/0001193125-26-332870.json","markdown":"https://secwatch.observer/filing/0001193125-26-332870.md","text":"https://secwatch.observer/filing/0001193125-26-332870.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1350653/000119312526332870/0001193125-26-332870-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1350653/000119312526332870/atec-20260804.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-04T20:20:18.244016+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}